Approval · Notice of Compliance 37169 · 2026
BAVENCIO: Notice of Compliance 37169
Issued March 23, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37169
- Date
- March 23, 2026
- Company
- Emd Serono A Division Of Emd Inc CanadaMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BAVENCIO | Not yet assigned | — |
Medicinal ingredients
- AVELUMAB 20 MG per ML